Details of the Drug

General Information of Drug (ID: DMTNQ5M)

Drug Name

QBX258

Indication

Disease Entry	ICD 11	Status	REF
Asthma	CA23	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01479595) A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma. U.S. National Institutes of Health.